Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti–tumor necrosis factor agents infliximab and etanercept

Braun, J.; Baraliakos, X.; Listing, J.; Sieper, J.

doi:10.1002/art.21197

Public

Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti–tumor necrosis factor agents infliximab and etanercept

Shared by NobleBlocks on Jul 28, 2005 • 12:00 AM UTC

Authors:

J. Braun

X. Baraliakos

J. Listing

Abstract

Abstract Objective To estimate the incidence of anterior uveitis in patients with ankylosing spondylitis (AS) who underwent anti–tumor necrosis factor (anti‐TNF) therapy, using data from recently performed trials. Methods Data from 4 placebo‐controlled studies with anti‐TNF agents in AS (2 with etan...

Discussions